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Background 
OXYSTEROLS 
•27 carbon oxidized cholesterol related molecules having 
additional –OH, C=O, epoxy, hydroperoxy moieties 
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Role of Oxysterols 
http://www.mdpi.com/2218-273X/2/1/76 
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Current methods for oxysterol analysis 
 - No current gold standard method 
• GC-MS 
Long runtime and complex derivatization 
• ESI- LC-MS/MS 
Derivatization is not a pre- requisite, longer runtime, poor 
sensitivity 
• APCI- LC-MS/MS 
No derivatization required, better sensitivity and reasonable 
runtimes 
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Specific aim of thesis  
 
To develop and validate an LC-MS- APCI method for 
measurement of multiple Oxysterols 
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Methods and Materials 
Instrumentation 
Shimadzu LC 
(2) LC-10ADvp Pumps 
SIL-HT Autosampler (low 
CTO-10AC Column Oven 
SPD-M10A Photo-diode Array 
 
Shimadzu MS 
LCMS-2010A System  
ESI & APCI interface 
 
Computer System and Software: 
LCMS Solution V3.20 
 
7 
Target Analytes 
• Method for analyzing a mixture of 13 Oxysterols 
 
 
 
 
 
 
 
 
 
 
• Deuterated Internal standard: 22 OHC-d7 
Standard Abbreviation 
22 Hydroxy cholesterol 22 OHC 
24 Hydroxy cholesterol 24 OHC 
25 Hydroxy cholesterol 25 OHC  
27 Hydroxy cholesterol 27 OHC 
7α  Hydroxy cholesterol 
7β Hydroxy cholesterol 
7α  OHC 
7β OHC 
7 Keto cholesterol 7 KC 
5β,6β Epoxycholesterol 5β,6β EC 
5α, 6α Epoxy cholesterol 5α, 6α EC 
4β Hydroxy cholesterol 4β OHC 
Desmosterol Desmo 
Zymosterol Zymo 
7 Dehydro cholsterol 7 DHC 
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MS Detection 
Flow Injection Analysis and Fragmentation 
- APCI + mode 
• Methanol as major mobile phase solvent 
• [M+ H- H2O]+ pattern 
 
             Example: 24 OHC 
 Mol wt: 403.2 
OH
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[M+H-H2O]+
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HPLC Conditions and Chromatography 
• Column: Supelcosil LC-18-S, 25cm x 4.6mm, 5µm (Sigma Aldrich) 
• Column oven temperature: 30°C 
• Mobile phase flow rate: 0.6 mL/minute 
• Mobile Phase: Gradient flow 
     A- 100% Methanol 
     B- Methanol: H2O :: 50:50 v/v 
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 Sample Preparation 
• 200 µL sample + 50 µL Internal standard + 10 µL BHT (5 µg/mL) 
 
• 875 µL 0.5M KOH in ethanol (cold saponification) for 3 hours 
 
 
 
• Neutralize with 25 µL of 85% Phosphoric acid + 1mL Water  
 
• Extract with Hexane ( 2 X 3 mL) [Rotate 5 min + centrifuge] 
 
• Separate Hexane phase and evaporate under nitrogen 
 
• Reconstitute using 250 µL Methanol and 50 µL HPLC grade Water 
Room  
Temp. 
11 
Results 
Stability: Are Oxysterols created during sample preparation? 
Purified Cholesterol (by HPLC) subject to different sample 
processing steps and analyzed by LCMS for formation of 
oxysterols 
 
•Trace formation of 7KC from cholesterol after subjecting 
cholesterol to alkaline hydrolysis 
•No significant increase in levels of other oxysterols 
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Stability: Are Oxysterols destroyed during sample preparation? 
Mixture of 13 oxysterol standards (13 Mix) analyzed before and 
after alkaline hydrolysis 
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Effect of Base 
without base
with base
* * * 
* % reduction >15% 
Significant decrease in the levels of 5α,6α EC, 5β,6β EC and 7α OHC, 
after treatment alkaline hydrolysis 
Note: In more recent validation experiments 7α OHC has appeared to 
be more stable 
13 
Recovery: 
Recovery for pure standards:  
% Recovery = Mean spiked plasma area – mean plasma area  x 100 %             
                    Mean unextracted area 
 
 
ND: Not detected 
• Poor recoveries for 7α OHC, 5β, 6β Epoxycholesterol and 4β epoxy 
cholesterol 
 
sample name 22 OHC 24 OHC 25 OHC  27 OHC 7a OHC 7 KC 5β 6β EC 5α 6α EC 4b OHC Desmo Zymo 7 DHC 
% Recovery 99.99 67.50 70.90 86.43 2.56 42.52 16.82 57.54 27.44 53.46 101.54 ND 
Internal Standard recovery: 
% Recovery =   Mean Extracted area  x 100 % 
              Mean unextracted area 
 
 
 
 
 
 
Sample 
Hexane Ext 
%recovery 
IS Reference  
(unextracted) 
100.00 
Fresh Plasma 
(Extracted) 
88.59 
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•Calibration curves generated with standards prepared at 5 levels 
for six oxysterols prepared in solvent as well as blank matrix 
•Observed concentration compared to the actual concentration 
   to estimate accuracy 
Example: 
 
 
 
 
 
 
 
• Comparable calibration curves (Linearity and Slope) in solvent 
and matrix for 24 OHC, 25 OHC, 7α OHC, 27 OHC, 7 KC and 
zymosterol--- no matrix effects  
Calibration curves and Matrix effects 
y = 0.0303x + 0.0403 
R² = 0.9979 
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Acceptable targets: 6 oxysterols 
• 24 OHC, 25OHC, 27 OHC, 7α OHC, 7 KC, Zymosterol 
are acceptable 
• The LOD and LLOQ between 5 to 10 ng/mL 
• Calibration curves are comparable in solvent and in matrix 
– indicating absence of matrix effects 
 
 
Parameter 
evaluated 22 OHC 24 OHC 25 OHC  27 OHC 7α OHC 7 KC 
5β 6β 
EC 
5α 6α 
EC 4b OHC Desmo Zymo 7 DHC 
22 OHC- 
d7 
Stability yes yes yes yes no yes no no yes yes yes yes yes 
Recovery 99.99 67.50 70.90 86.43 2.56 42.52 16.82 57.54 27.44 53.46 101.54 ND 88.59 
Solvent 
correlation coeff. ND 0.9979 0.9937 0.9973 0.9972 0.948 ND ND ND ND 0.9961 ND  
Matrix 
correlation coeff. ND 0.9932 0.9805 0.9978 0.7969 0.9712 ND ND ND ND 0.9581 ND  
Matrix effect ND no no no yes no ND ND ND ND no ND no 
Workable for 
Validation No yes yes yes no yes no no no no yes no - 
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Future Directions 
Perform full method validation of the acceptable target 
oxysterols according to US FDA/ EPA guidelines for method 
validation 
- Linearity and range 
- Accuracy 
- Precision 
- Detection and Quantitation limits 
- Recovery 
- Selectivity 
- Sensitivity                                                                           
- Matrix effects 
- Carry over effect 
- Stability studies 
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Conclusion 
Target Studies 
• Oxysterol levels in traumatic brain injury (Dr. Browne, Dr. 
Senthilvelan Manohar) 
 
• Oxysterols in Multiple Sclerosis (Dr. Browne, Dr. 
Ramanathan and Dr. Weinstock-Gutteman) 
 
• Study Oxysterol and Cholesterol metabolism in the 
Ovarian Folliculogenesis (Dr. Browne and Dr. Fujimoto) 
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Thank You! 
 
 
 
 
Questions  
